Huang Huajie, Wang Jian, Liang Yingyin, Wei Xiaofeng, Guo Dan, Sun Hengbiao, Zhang Xuelian, Xu Xiangmin, Xiong Fu
Department of Medical Genetics, School of Basic Medical Sciences, Southern Medical University, Guangzhou, Guangdong 510515, P.R. China.
Medical Genetic Centre, Guangdong Women and Children Hospital, Guangzhou, Guangdong 511400, P.R. China.
Exp Ther Med. 2020 Dec;20(6):152. doi: 10.3892/etm.2020.9281. Epub 2020 Oct 6.
Hypophosphatasia (HPP) is a rare hereditary systemic disease that is characterized by defective bone and/or dental mineralization, and is caused by mutations in the alkaline phosphatase gene (ALPL). The present study investigated the ALPL mutation in a Chinese Han family with HPP and studied the pathogenesis of the mutations of the ALPL gene. DNA was extracted from peripheral venous blood of the family members. Sanger sequencing was used to screen the mutations. Associations between pathogenesis for both mutations were analyzed by bioinformatics, subcellular localization, measurement of enzyme activity and western blotting. Sanger sequencing revealed the compound heterozygous mutations c.203C>T (p.T68M) and c.571G>A (p.E191K). The mutations were located at exon 4 and 6 of the ALPL gene and were predicted by Polyphen-2 analysis to be harmful. Protein analysis indicated a decrease in mature protein production and lower enzyme activity in 293T cells transfected with plasmids carrying the mutations. The ALPL gene was cloned into the pcDNA3.1(+) vector and mutant plasmids ALPL-pT68M and ALPL-pE191K were constructed. Immunofluorescence observed in cells transfected with the ALPL-pE191K mutant plasmid was mainly located in the cell membrane. However, staining in the cytoplasm was increased compared with the wild type, and almost no fluorescence was identified in 293T cells transfected with the ALPL-pT68M mutant plasmid. The present findings demonstrated that the compound heterozygous c.571G>A and c.203C>T mutations may contribute to childhood HPP by resulting in mislocalization, decreased protein expression and loss of enzyme activity in a Han Chinese family. The results of the current study may provide insights into the potential molecular mechanism of HPP.
低磷性骨软化症(HPP)是一种罕见的遗传性全身性疾病,其特征为骨骼和/或牙齿矿化缺陷,由碱性磷酸酶基因(ALPL)突变引起。本研究调查了一个患HPP的中国汉族家系中的ALPL突变,并研究了ALPL基因突变的发病机制。从家庭成员的外周静脉血中提取DNA。采用Sanger测序法筛选突变。通过生物信息学、亚细胞定位、酶活性测定和蛋白质印迹分析两种突变的发病机制之间的关联。Sanger测序揭示了复合杂合突变c.203C>T(p.T68M)和c.571G>A(p.E191K)。这些突变位于ALPL基因的第4和第6外显子,经Polyphen-2分析预测为有害突变。蛋白质分析表明,用携带突变的质粒转染的293T细胞中成熟蛋白产量降低,酶活性降低。将ALPL基因克隆到pcDNA3.1(+)载体中,构建突变体质粒ALPL-pT68M和ALPL-pE19I K。在转染了ALPL-pE191K突变体质粒的细胞中观察到的免疫荧光主要位于细胞膜。然而,与野生型相比,细胞质中的染色增加,而在转染了ALPL-pT68M突变体质粒的293T细胞中几乎未检测到荧光。本研究结果表明,复合杂合c.571G>A和c.203C>T突变可能通过导致定位错误、蛋白质表达降低和酶活性丧失,从而导致一个中国汉族家系中的儿童HPP。本研究结果可能为HPP的潜在分子机制提供见解。